Transposition of the great arteries and conotruncal cardiac anomaly

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

Regulatory Watchboard

No FDA or trial events recorded yet for Transposition of the great arteries and conotruncal cardiac anomaly.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Transposition of the great arteries and conotruncal cardiac anomaly.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

TOBRADEX ST

(TOBRAMYCIN / DEXAMETHASONE)standard

Harrow Eye, LLC

Corticosteroid [EPC]

12.1 Mechanism of Action Dexamethasone is a potent corticoid. Corticoids suppress the inflammatory response to a variety of agents and they can delay ...

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Transposition of the great arteries and conotruncal cardiac anomaly.
Search all trials →

Search clinical trials for Transposition of the great arteries and conotruncal cardiac anomaly →

Recent News & Research

1 article

FDA Approves TOBRADEX ST

TOBRADEX ST (DEXAMETHASONE) received FDA approval.

Browse all Transposition of the great arteries and conotruncal cardiac anomaly news →

Specialist Network

No specialists currently listed for Transposition of the great arteries and conotruncal cardiac anomaly.

View all Transposition of the great arteries and conotruncal cardiac anomaly specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles